ストックスクリーナーアプリを入手
10.26
0.19%
-0.02
アフターアワーズ：
10.26
前日終値:
$10.28
開ける：
$10.24
24時間の取引高:
802
Relative Volume:
0.06
時価総額：
$226.34M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.39%
1か月 パフォーマンス:
+0.98%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$10.24
$10.26
1週間の範囲:
$10.18
$10.28
52週間の値動き範囲:
$10.11
$10.35
Helix Acquisition Corp Iii Stock (HLXC) Company Profile
名前
Helix Acquisition Corp Iii
セクター
電話
(857) 702-0370
住所
C/O CORMORANT ASSET MANAGEMENT LP, BOSTON
Compare HLXC vs LION, XXI, UMAC, BCSS, EVAC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HLXC
Helix Acquisition Corp Iii
|
10.26 | 226.78M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.69 | 3.93B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
5.34 | 1.91B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
22.85 | 1.14B | 17.25M | -5.64M | -40.16M | -0.3337 |
BCSS
Bain Capital Gss Investment Corp
|
10.21 | 598.02M | 0 | 8.29M | -686.50K | 0.142 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.16 | 594.71M | 0 | 12.80M | -714.00K | 0.2184 |
Helix Acquisition Corp Iii (HLXC) 最新ニュース
TRADING UPDATES: Unicorn Mineral; Helix Exploration agree acquisitions - London South East
MoonLake Immunotherapeutics Signs Manufacturing Agreement with Vetter Pharma – SEC 8-K Filing Details 8 - Minichart
EQIX Q1 2026 Earnings: EPS Slightly Misses Estimates; Stock Edges LowerDividend Earnings Report - The Legal Advocate
LIEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Helix Acquisition Corp. III (HLXC) Holds Steady at $10.22, Signaling Stability in SPAC TerritoryOBV Breakout - The Legal Advocate
India’s Engineering Goods Exports Rise 8.8% in April Despite Decline in UAE, Saudi Arabia ShipmentsEPS Growth Rate - The Legal Advocate
Helix Acquisition Corp. III (HLXC) Holds Steady Near Trust Value Amid Minimal MovementWeekly Profile - The Legal Advocate
Cuprina Holdings (CUPR) Slides 9%: Key Support Levels Under PressureVolume Nodes - The Legal Advocate
Wall Street Analyst Sentiment on Intuitive Surgical: A Closer LookRevenue Per Share - thelegaladvocate.com
AI Adoption Faces Cost Hurdle: Reports Suggest Technology May Be More Expensive Than Human LaborEBITDA Analysis - newsline.com
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING - Yahoo Finance
BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid - The Manila Times
Apollo Hospitals Q4FY26 Net Profit Jumps 36% to ₹529 Crore, Board Approves Maternity Venture MergerCFO Commentary Report - The Legal Advocate
Airship AI (AISP) Q3 2025 Earnings Miss by Significant: Key TakeawaysCore Business Growth - thelegaladvocate.com
Helix Acquisition Corp. IIClass A Ordinary Shares (NQ: HLXB - The Chronicle-Journal
ADAR1/Schneeberger report 1,000,000 HLXC shares (HLXC) - Stock Titan
Number of shareholders of Helix Acquisition Corp. III – NASDAQ:HLXC - TradingView
1.25M shares disclosed by Nantahala in HLXC (HLXC) Schedule 13G - Stock Titan
Helix Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Helix Acquisition Corp. III (HLXC) earns $0.84M as SPAC trust hits $173.6M - Stock Titan
Balyasny group reports 1.24M shares in Helix Acquisition Corp. III (HLXC) - Stock Titan
Affinity Asset Advisors (HLXC) reports 1.25M shares, a 7% stake - Stock Titan
SUMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
[SCHEDULE 13G] Helix Acquisition Corp. III Passive Investment Disclosure (>5%) - Stock Titan
SUMA PE Ratio & Valuation, Is SUMA Overvalued - Intellectia AI
TradingKey - TradingKey
HLXC Helix releases quarterly earnings report but revenue and profit data remain undisclosed to investors. - Newser
HLXC (Helix) acquisition Corp III keeps quiet as investors anticipate merger pipeline updates and quarterly details.Financial Health - Newser
How sustainable is Helix (HLXC) profit margins? (Ticks Higher) 2026-05-06Popular Picks - newser.com
Helix Acquisition Corp. III (HLXC) Schedule 13G/A lists Millennium holdings - Stock Titan
HELX ACQUPAR : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
BBOT SEC FilingsBridgeBio Oncology Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
AnaptysBio (NASDAQ: ANAB) details spin-off, pay and board changes - Stock Titan
Latest BBOT NewsBBOT Presents Preclinical Data Demonstratin... - Stock Titan
Esports Entertainment Group Completes Acquisition of Helix eSports and ggCircuit - TMX Newsfile
KMDA Kamada reports Q4 2025 EPS below analyst estimates as shares post tiny gains in daily trading.Profit Cycle Analysis - The Legal Advocate
HLXC Helix releases latest quarterly earnings, outlines core strategic priorities to drive long-term business growth. - newsline.com
Eagle (EIIA) Stock Liquidity (Technical Weakness) 2026-04-20Mid Cap Momentum - The Legal Advocate
Is Now a Good Time to Buy Helix (HLXC)? (Unchanged) 2026-04-18Expert Stock Picks - Xã Vĩnh Công
Helix Holdings Iii Llc Net Worth (2026) - GuruFocus
Helix (HLXC) Stock Float (Motionless) 2026-04-16Community Buy Alerts - UBND thành phố Hải Phòng
Press Releases about Helix Biopharma Corp (Toronto Stock Exchange:HBP) - FinancialContent
symbol__ Stock Quote Price and Forecast - CNN
HLXC Stock Price, News & Analysis - Stock Titan
Downgrade Watch: Is Helix Acquisition Corp II stock a hidden gemMarket Risk Summary & Low Volatility Stock Suggestions - baoquankhu1.vn
Hedge Fund Moves: Will Helix Acquisition Corp II benefit from green energy policiesQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ELME Stock Analysis: Elme Communities 2.05 Price Level Modest Gain Performance Overview - newsline.com
Oneim Acquisition Corp. (OIMAU) Insider Ownership & Holdings - Yahoo! Finance Canada
HMH Holding Inc. Announces Closing of Initial Public Offering - Yahoo Finance
Helix Acquisition Corp Iii (HLXC) 財務データ
Helix Acquisition Corp Iii (HLXC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.00%
1.07%
大文字化:
|
ボリューム (24 時間):